DYAZIDE (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the DYAZIDE drug offered from GlaxoSmithKline LLC. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | hydrochlorothiazide and triamterene |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1994-03-30 |
| END MARKETING DATE: | 0000-00-00 |
DYAZIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | DYAZIDE from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 37.5(mg/1; mg/1) |
| START MARKETING DATE: | 1994-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0007-3650_25b16f40-16dd-429b-ba22-5878756b0fe1 |
| PRODUCT NDC: | 0007-3650 |
| APPLICATION NUMBER: | NDA016042 |
Other HYDROCHLOROTHIAZIDE; TRIAMTERENE Pharmaceutical Manufacturers / Labelers:
